These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 1284429)

  • 21. Zymogen activation: effect of peptides sequentially related to the bovine beta-trypsin N-terminus on Kazal inhibitor and benzamidine binding to bovine trypsinogen.
    Ascenzi P; Coletta M; Amiconi G; Bolognesi M; Guarneri M; Menegatti E
    J Mol Recognit; 1988 Jun; 1(3):130-7. PubMed ID: 3273224
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Are factor Xa inhibitors superior to thrombin inhibitors in anticoagulation?
    Stürzebecher J; Stürzebecher U
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):152-6. PubMed ID: 2459011
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interactions of thrombin with benzamidine-based inhibitors.
    Stürzebecher J; Vieweg H; Wikström P; Turk D; Bode W
    Biol Chem Hoppe Seyler; 1992 Jul; 373(7):491-6. PubMed ID: 1515080
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site.
    Katz BA; Elrod K; Luong C; Rice MJ; Mackman RL; Sprengeler PA; Spencer J; Hataye J; Janc J; Link J; Litvak J; Rai R; Rice K; Sideris S; Verner E; Young W
    J Mol Biol; 2001 Apr; 307(5):1451-86. PubMed ID: 11292354
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of serine proteinases by benzamidine derivatives.
    Walsmann P
    Acta Biol Med Ger; 1977; 36(11-12):1931-7. PubMed ID: 616739
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Elaborate manifold of short hydrogen bond arrays mediating binding of active site-directed serine protease inhibitors.
    Katz BA; Elrod K; Verner E; Mackman RL; Luong C; Shrader WD; Sendzik M; Spencer JR; Sprengeler PA; Kolesnikov A; Tai VW; Hui HC; Breitenbucher JG; Allen D; Janc JW
    J Mol Biol; 2003 May; 329(1):93-120. PubMed ID: 12742021
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Bisbenzamidine Phosphonate as a Janus-faced Inhibitor for Trypsin-like Serine Proteases.
    Häußler D; Scheidt T; Stirnberg M; Steinmetzer T; Gütschow M
    ChemMedChem; 2015 Oct; 10(10):1641-6. PubMed ID: 26306030
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of bovine and human thrombins by derivatives of benzamidine.
    Stürzebecher J; Walsmann P; Voigt B; Wagner G
    Thromb Res; 1984 Dec; 36(5):457-65. PubMed ID: 6523450
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Influence of benzamidine derivatives on thrombin-induced platelet reactions.
    Glusa E; Hoffmann A; Markwardt F
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1982; 109(1):98-106. PubMed ID: 6177615
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Synthetic inhibitors of bovine factor Xa and thrombin comparison of their anticoagulant efficiency.
    Stürzebecher J; Stürzebecher U; Vieweg H; Wagner G; Hauptmann J; Markwardt F
    Thromb Res; 1989 May; 54(3):245-52. PubMed ID: 2749616
    [TBL] [Abstract][Full Text] [Related]  

  • 31. On the modeling of snake venom serine proteinase interactions with benzamidine-based thrombin inhibitors.
    Henriques ES; Fonseca N; Ramos MJ
    Protein Sci; 2004 Sep; 13(9):2355-69. PubMed ID: 15322279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Thermodynamic evaluation and modeling of proton and water exchange associated with benzamidine and berenil binding to beta-trypsin.
    Pereira MT; Silva-Alves JM; Martins-José A; Lopes JC; Santoro MM
    Braz J Med Biol Res; 2005 Nov; 38(11):1593-601. PubMed ID: 16258627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Synthetic inhibitors of serine proteinases. 20. The inhibitory effect of benzo condensed lactam derivatives of benzamidine on trypsin, plasmin and thrombin].
    Walsmann P; Markwardt F; Stürzebecher J; Wagner G; Wunderlich I
    Pharmazie; 1979; 34(3):194-5. PubMed ID: 156372
    [No Abstract]   [Full Text] [Related]  

  • 34. Active site mapping of trypsin, thrombin and matriptase-2 by sulfamoyl benzamidines.
    Dosa S; Stirnberg M; Lülsdorff V; Häußler D; Maurer E; Gütschow M
    Bioorg Med Chem; 2012 Nov; 20(21):6489-505. PubMed ID: 23026080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A serine protease-inhibitory benzamidine derivative inhibits the growth of human colon carcinoma cells.
    Nishimura Y; Yasui W; Yoshida K; Matsuyama T; Dohi K; Tahara E
    Jpn J Cancer Res; 1992 Jul; 83(7):723-8. PubMed ID: 1517149
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of four human serine proteases by substituted benzamidines.
    Andrews JM; Roman DP; Bing DH
    J Med Chem; 1978 Dec; 21(12):1202-7. PubMed ID: 152812
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Inhibition of activated protein C by benzamidine derivatives.
    Stürzebecher J; Prasa D; Taby O
    Thromb Res; 1993 Mar; 69(6):533-9. PubMed ID: 8503121
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage between proton binding and amidase activity in human gamma-thrombin.
    De Cristofaro R; Fenton JW; Di Cera E
    Biochemistry; 1992 Feb; 31(4):1147-53. PubMed ID: 1310421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative molecular modeling analysis of-5-amidinoindole and benzamidine binding to thrombin and trypsin: specific H-bond formation contributes to high 5-amidinoindole potency and selectivity for thrombin and factor Xa.
    Zhou Y; Johnson ME
    J Mol Recognit; 1999; 12(4):235-41. PubMed ID: 10440994
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Low molecular weight activated protein C inhibitors as a potential treatment for hemophilic disorders.
    De Nanteuil G; Gloanec P; Béguin S; Giesen PL; Hemker HC; Mennecier P; Rupin A; Verbeuren TJ
    J Med Chem; 2006 Aug; 49(17):5047-50. PubMed ID: 16913694
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.